Clinical Development Funding

LA JOLLA, Calif., March 13, 2026 Equillium Inc., a biotechnology company developing novel therapies for severe autoimmune and inflammatory...

JUPITER, Fla., Feb. 23, 2026 — Jupiter Neurosciences, a clinical-stage pharmaceutical company focused on neuroinflammation and central nervous system...

Toronto, Ontario, January 16, 2026 — Cardiol Therapeutics announced a bought deal private placement financing for gross proceeds of...